Clinical Trial Update: PASS to Assess Cardiovascular and Cerebrovascular Events in COPD Patients Initiating Fixed Triple Therapy (DPI or pMDI)

View source ↗

Summary

Post-authorization safety study (PASS) to evaluate cardiovascular and cerebrovascular events in COPD patients initiating fixed triple therapy delivered by a DPI…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Fixed triple therapy (DPI or pMDI)

Snippet

Sponsor: Chiesi Farmaceutici S.p.A. | Conditions: Chronic Obstructive Pulmonary Disease | Status: RECRUITING